Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Koren · SciRah

Researcher profile · Semantic Scholar

A. Koren

Share profile

A. Koren — researcher profile on SciRah

h-index: 13
Works: 58
Citations: 832

Most-cited papers

Sex Differences in the Use of Statins in Community Practice: The Patient and Provider Assessment of Lipid Management (PALM) Registry
M. Nanna, Tracy Y. Wang, Qun Xiang, A. Goldberg +9 more
2019Circulation. Cardiovascular Quality and Outcomes261 citations Open access
Semantic Scholar
Left ventricular mass change during treatment and outcome in patients with essential hypertension.
M. Koren, Roy J. Ulin, A. Koren, J. Laragh +1 more
2002American Journal of Hypertension125 citations Open access
Semantic Scholar
Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk
I. Lin, J. Sung, R. Sanchez, U. Mallya +5 more
2016Journal of Managed Care & Specialty Pharmacy93 citations Open access
Semantic Scholar
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
T. Mahmood, J. Minnier, Matthew K. Ito, Qian H. Li +4 more
2020European Journal of Preventive Cardiology27 citations Open access
Semantic Scholar
Practice-level Variation in Statin Use and Low-Density Lipoprotein Cholesterol Control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) Registry
M. Nanna, A. Navar, Tracy Y. Wang, Shuang Li +9 more
2019American Heart Journal27 citations Open access
Semantic Scholar
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
P. McCullough, C. Ballantyne, Santosh K. Sanganalmath, G. Langslet +5 more
2018American Journal of Cardiology25 citations Open access
Semantic Scholar
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials
O. Ganda, J. Plutzky, Santosh K. Sanganalmath, Maja Bujas-Bobanovic +4 more
2018Diabetes, obesity and metabolism21 citations Open access
Semantic Scholar
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers
M. Ezekowitz, K. Ellenbogen, J. Dimarco, K. Kaszala +3 more
2015Journal of interventional cardiac electrophysiology16 citations Open access
Semantic Scholar
Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database.
K. Schulman, L. Lamerato, M. Dalal, J. Sung +4 more
2015Value in Health16 citations Open access
Semantic Scholar
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study
M. Vámos, H. Calkins, P. Kowey, C. Torp-Pedersen +4 more
2019Clinical Cardiology15 citations Open access
Semantic Scholar
A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records
M. Panaccio, G. Cummins, C. Wentworth, S. Lanes +4 more
2015Clinical Epidemiology14 citations Open access
Semantic Scholar
Controlled‐Release Doxazosin as Combination Therapy in Hypertension: The GATES Study
Henry R. Black, M. Keck, P. Meredith, K. Bullen +2 more
2006The Journal of Clinical Hypertension14 citations Open access
Semantic Scholar
US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
Jonathan G. Tardos, C. Ronk, Miraj Y. Patel, A. Koren +1 more
2021Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease13 citations Open access
Semantic Scholar
Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©
T. A. Jacobson, S. Edelman, N. Galipeau, A. Shields +3 more
2016Patient13 citations Open access
Semantic Scholar
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study
C. Blomström-Lundqvist, N. Marrouche, S. Connolly, Valérie Corp Dit Genti +3 more
2020Clinical Cardiology12 citations Open access
Semantic Scholar
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.
K. Ferdinand, T. A. Jacobson, A. Koren, J. Elassal +2 more
2019Journal of Clinical Lipidology12 citations Open access
Semantic Scholar
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
Y. Xian, A. Navar, Shuang Li, Zhuokai Li +9 more
2019Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease12 citations Open access
Semantic Scholar
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
H. Ginsberg, Jaakko Tuomilehto, G. Hovingh, B. Cariou +6 more
2019Cardiovascular Drugs and Therapy12 citations Open access
Semantic Scholar
Alirocumab in high-risk patients: Observations from the open-label expanded use program.
C. Glueck, Alan S. Brown, A. Goldberg, J. Mckenney +4 more
2018Journal of Clinical Lipidology12 citations Open access
Semantic Scholar
Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
J. Wharton, J. Piccini, A. Koren, S. Huse +1 more
2022Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease11 citations Open access
Semantic Scholar
Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease
U. Mallya, S. Boklage, A. Koren, Thomas E. Delea +1 more
2017PharmacoEconomics (Auckland)9 citations Open access
Semantic Scholar
Evaluation of dronedarone use in the US patient population between 2009 and 2010: a descriptive study using a claims database.
Shujun Gao, J. Juhaeri, Heather A Schiappacasse, A. Koren +1 more
2011Clinical Therapeutics9 citations
Semantic Scholar
Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
A. Ha, J. Stewart, G. Klein, D. Roy +3 more
2020American Heart Journal8 citations
Semantic Scholar
Assessment of dronedarone utilization using US claims databases.
Jasmanda Wu, Jane Thammakhoune, Wan-Ju S. Dai, A. Koren +4 more
2014Clinical Therapeutics8 citations
Semantic Scholar
Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
Michael H. Kim, Jay Lin, M. Jhaveri, A. Koren
2014Advances in Therapy8 citations Open access
Semantic Scholar
Placing in-vitro heteroresistance in the context of clinical results.
M. Bassetti, R. Echols, A. Koren, A. Karas +3 more
2021Lancet. Infectious Diseases (Print)7 citations Open access
Semantic Scholar
Beliefs, Risk Perceptions and Lipid Management among Patients with and without Diabetes: Results from the PALM Registry
Angela Lowenstern, Shuang Li, S. Virani, A. Navar +8 more
2020American Heart Journal7 citations Open access
Semantic Scholar
Abstract 15020: A Placebo-Controlled, Double-Blind, Randomized, Multicenter Study to Assess the Effects of Dronedarone on Atrial Fibrillation Burden in Subjects with Permanent Pacemakers (HESTIA)
M. Ezekowitz, J. Dimarco, K. Kaszala, K. Ellenbogen +2 more
20125 citations
Semantic Scholar
Design and Rationale of a Pragmatic Randomized Clinical Trial of Early Dronedarone versus Usual Care to Change and Improve Outcomes in Persons with First-Detected Atrial Fibrillation - The CHANGE AFIB Study.
Sean D. Pokorney, Hayley Nemeth, K. Chiswell, Christine Albert +19 more
2024American Heart Journal4 citations
Semantic Scholar
Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors.
A. Go, A. Ambrosy, K. Kheder, D. Fan +6 more
2019American Journal of Cardiology4 citations
Semantic Scholar
Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’
A. Koren, A. Karas, R. Echols
2021Clinical drug investigation3 citations Open access
Semantic Scholar
Abstract 17086: Alirocumab LDL-C-Lowering Efficacy in Patients With Moderate CKD
P. Toth, C. Cannon, J. Kastelein, H. Colhoun +4 more
2015Circulation3 citations
Semantic Scholar
Abstract 3362: Effects of Ranolazine as Monotherapy and Combination Therapy on Rate Pressure Product at Rest and During Exercise: Results from the MARISA and CARISA trials
P. Stone, B. Chaitman, A. Koren, M. Crager
20063 citations
Semantic Scholar
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials
M. Thind, H. Crijns, G. Naccarelli, J. Reiffel +4 more
2020Cardiovascular Electrophysiology2 citations Open access
Semantic Scholar
a common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records
M. Panaccio, G. Cummins, C. Wentworth, S. Lanes +4 more
20152 citations
Semantic Scholar
PRACTICE-LEVEL VARIATION IN STATIN USE AND LDL-C CONTROL IN THE UNITED STATES: RESULTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY
M. Nanna, A. Navar, Tracy Y. Wang, Shuang Li +9 more
2019Journal of the American College of Cardiology1 citations Open access
Semantic Scholar
Development and Content Validation of a Patient-Reported Outcome Measure to Evaluate Statin Intolerance in the Real World
T. A. Jacobson, S. Edelman, Michael H. Davidson, N. Galipeau +3 more
20161 citations Open access
Semantic Scholar
An efficacy and safety study of doxazosin gastrointestinal therapeutic system as combination therapy in hypertensive patients
H. Black, M. Keck, P. Meredith, K. Bullen +2 more
20041 citations Open access
Semantic Scholar
CARDIOVASCULAR HOSPITALIZATION AND REPEAT ABLATION RATES FOLLOWING CATHETER ABLATION AMONG ATRIAL FIBRILLATION PATIENTS TREATED WITH DRONEDARONE VS. SOTALOL
J. Wharton, J. Piccini, A. Koren, S. Huse +1 more
20200 citations Open access
Semantic Scholar
STATIN THERAPY IN PATIENTS WITH CEREBROVASCULAR DISEASE VERSUS CORONARY ARTERY DISEASE: INSIGHTS FROM THE PALM REGISTRY
Y. Xian, A. Navar, Shuang Li, Zhuokai Li +9 more
2019Journal of the American College of Cardiology0 citations Open access
Semantic Scholar
P1903Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials
M. Thind, H. Crijns, G. Naccarelli, J. Reiffel +4 more
2019European Heart Journal0 citations
Semantic Scholar
P1034Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial
M. Vámos, H. Calkins, P. Kowey, C. Torp-Pederson +4 more
2019European Heart Journal0 citations
Semantic Scholar
P4784Efficacy and safety of dronedarone by duration of atrial fibrillation history: a post-hoc analysis of the ATHENA trial
C. Blomstrom-Lundqvist, N. Marrouche, S. Connolly, V. C. D. Genti +3 more
2019European Heart Journal0 citations
Semantic Scholar
PATIENT PERCEPTIONS AND MANAGEMENT OF CHOLESTEROL AMONG INDIVIDUALS WITH OR WITHOUT DIABETES IN COMMUNITY PRACTICE: RESULTS FROM THE PALM REGISTRY
Angela Lowenstern, A. Navar, Shuang Li, S. Virani +7 more
2019Journal of the American College of Cardiology0 citations Open access
Semantic Scholar
ALIROCUMAB IN HIGH-RISK PATIENTS WITH BASELINE LDL-C ≥160 MG/DL: FINDINGS FROM THE COMPASSIONATE USE PROGRAM
C. Glueck, Alan S. Brown, A. Goldberg, J. Mckenney +4 more
20170 citations Open access
Semantic Scholar
Abstract 15710: Impact of Age on the Efficacy and Safety of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia
H. Ginsberg, J. Tuomilehto, G. Hovingh, B. Cariou +6 more
20170 citations
Semantic Scholar
Abstract 15748: Alirocumab Efficacy and Safety by Race and Ethnicity: Analysis From Three ODYSSEY Phase 3 Trials
K. Ferdinand, T. A. Jacobson, K. Williams, A. Koren +3 more
20170 citations
Semantic Scholar
Abstract 16873: Safety and Efficacy of Alirocumab in Patients With Atherosclerotic Cardiovascular Disease, Based on Statin Intensity: Pooled Analyses of 5 Placebo-controlled Phase 3 Trials
C. Ballantyne, P. McCullough, Santosh K. Sanganalmath, A. Koren +2 more
20160 citations
Semantic Scholar
Abstract 16528: Impact of Alirocumab on Apolipoprotein B, Non-High-Density Lipoprotein Cholesterol, and Triglycerides in Patients With and Without Moderate Chronic Kidney Disease
P. Toth, M. Banach, A. Koren, M. Louie +3 more
20160 citations
Semantic Scholar
Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers
M. Ezekowitz, K. Ellenbogen, J. Dimarco, K. Kaszala +3 more
2015Journal of interventional cardiac electrophysiology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Goldberg×9
Invite
A. Goldberg — researcher profile on SciRah
M. Louie×9
Invite
M. Louie — researcher profile on SciRah
Tracy Y. Wang×7
Invite
Tracy Y. Wang — researcher profile on SciRah
J. Robinson×7
Invite
J. Robinson — researcher profile on SciRah

×7

Invite

V. Roger — researcher profile on SciRah

Invite

S. Virani — researcher profile on SciRah

Invite

E. Peterson — researcher profile on SciRah

Invite

A. Navar — researcher profile on SciRah

Invite

Zhuokai Li — researcher profile on SciRah

Invite

Shuang Li — researcher profile on SciRah

Invite

M. Wieloch — researcher profile on SciRah

Invite

P. Wilson — researcher profile on SciRah